Provided by Tiger Trade Technology Pte. Ltd.

VanEck Pharmaceutical ETF

107.44
-0.6200-0.57%
Volume:140.75K
Turnover:15.10M
Market Cap:1.02B
PE:87.06
High:108.01
Open:107.78
Low:106.86
Close:108.06
52wk High:118.00
52wk Low:90.60
Shares:9.54M
Float Shares:9.54M
Volume Ratio:0.95
T/O Rate:1.48%
Dividend:2.14
Dividend Rate:1.99%
EPS(TTM):1.23
EPS(LYR):0.7765
ROE:--
ROA:--
PB:--
PE(LYR):138.37

Loading ...

Wall Street Analysts Are Neutral on Top Healthcare Picks

TIPRANKS
·
Sep 23

Cboe data shows mixed options sentiment in Novo Nordisk with shares down 0.89%

TIPRANKS
·
Sep 23

AbbVie Tells USTR Germany Drug Pricing Reforms Cut Innovative Medicine Value by Nearly 54%

Reuters
·
Sep 23

Eli Lilly Price Target Maintained with a $1250.00/Share by TD Cowen

Dow Jones
·
Sep 22

European Pharma Leaders Push for National Reforms to Boost Investment

Dow Jones
·
Sep 22

Viking Therapeutics Stock Surges 35%. It Could Challenge Lilly and Novo's Obesity Empire

Dow Jones
·
Sep 22

Analysts Have Conflicting Sentiments on These Healthcare Companies: Pyxis Oncology (PYXS), Moderna (MRNA) and Eli Lilly & Co (LLY)

TIPRANKS
·
Sep 22

Weight-Loss Drug Developers Line up to Tap Lucrative Market as Competition Heats Up

Reuters
·
Sep 22

Novo Nordisk (NVO) Receives a Hold from Jefferies

TIPRANKS
·
Sep 22

Viking Therapeutics Stock Surges 36%. it Could Challenge Lilly and Novo's Obesity Empire.

Dow Jones
·
Sep 22

Hope Fuels Markets but Reality Could Bite

Dow Jones
·
Sep 22

Merck Gets FDA Label Update for WINREVAIR Based on HYPERION Trial

MT Newswires Live
·
Sep 22

Merck says FDA approves update for U.S. product label for Winrevair

TIPRANKS
·
Sep 22

U.S. FDA Approves Update to the Label for Winrevair to Include Data from the Phase 3 Hyperion Trial Evaluating Adults Recently Diagnosed with Pulmonary Arterial Hypertension

Reuters
·
Sep 22

Merck Says Phase 3 Hyperion Trial Shows Winrevair Cuts PAH Clinical Worsening Risk 76%

Reuters
·
Sep 22

Novo Nordisk Investor Day Disappointed

Dow Jones
·
Sep 22

AbbVie: EC approves Rinvoq to treat polyarticular juvenile idiopathic arthritis

TIPRANKS
·
Sep 22

Market Chatter: Novo Nordisk CEO Eyes M&A to Fill Gaps in Drug Portfolio

MT Newswires Live
·
Sep 22

Novo Stock (NVO): Deutsche Bank Keeps Sell Rating, Says Growth Strategy ‘Underwhelming on Multiple Fronts’

TIPRANKS
·
Sep 22

Novo Nordisk (0QIU) Receives a Hold from Berenberg Bank

TIPRANKS
·
Sep 22